Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 12th April 2023
This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-system interactions. We cover the role of AI Daily Roundup and its application in various industries and daily lives.
Verint, The Customer Engagement Company, announced that advanced capabilities for Verint Intelligent Virtual Assistant (IVA) will be available on April 19 and deliver a conversation design platform that enables teams to design, deploy, and improve IVAs faster, collaboratively and at scale. Verint IVA is part of Verint Customer Engagement Platform powered by Verint Da Vinci AI to activate insights and automate experiences across the enterprise.
ArteraAI and American Cancer Society Announce New Relationship
ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American Cancer Society, a leading cancer-fighting organization, announce a new relationship that will allow both parties to contribute to making progress against the more than 200 diseases we call cancer.
AiAdvertising Receives $5 Million Equity Investment to Fuel Next Phase of Growth
AiAdvertising, a next-generation AdTech company focused on harnessing the power of artificial intelligence (AI) and machine learning (ML) for today’s marketing leaders, announced that the Company has entered into a securities purchase agreement with Hexagon Partners, a Texas-based investment company, for a strategic investment of $5 million and potentially up to $9.25 million. The transaction is expected to close today.
Avalon GloboCare Corp, a developer of innovative cell-based technology, cellular therapy and precision diagnostics, announced that it has signed an agreement with Qi Diagnostics Limited (“Qi Diagnostics”), for exclusive distribution rights to market Qi Diagnostics’ KetoAir™ breathalyzer device and related accessories, including current and future models, in North America, South America, the U.K. and the European Union. KetoAir™ functions as companion diagnostic and monitoring device for ketogenic dietary management and will initially target the diabetes reversal and weight management markets.
AITX Applauds Circadian Risk’s Partnership with Setracon Enterprise Risk Management Services
Circadian Risk, a pioneer in enterprise risk analysis SaaS and scenario-based assessment products, announced a strategic partnership with Setracon Enterprise Risk Management Services, which helps enterprise organizations meet risk process and security management standards. Setracon will adopt the Circadian Risk Enhanced Solutions software suite, and Setracon Founder and President Jeffrey Slotnick and Chief Security & Technology Officer (CSTO) Michael Keneipp will join the Circadian Risk advisory team.
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.